
Proveri Inc. investigators are examining whether measurements of gene activity of neighboring stroma cells of the prostate also predict future behavior of the tumor – whether the tumor is indolent with little potential for growth or is aggressive which may further guide treatment decisions such as the adoption of watchful-waiting/active surveillance regimens.